Fatty Acyl Sarcosines and Sarcosinate Salts: CIR Safety Assessment Summary
CIR safety assessment summary for Fatty Acyl Sarcosines and Sarcosinate Salts: ingredients reviewed, panel verdict, use concentration context, conditions,.
Fatty Acyl Sarcosines and Sarcosinate Salts appears in a CIR safety assessment covering Fatty Acyl Sarcosines and Sarcosinate Salts. The panel verdict for the report is safe with restrictions. The Panel concluded that the following ingredients are safe as used in cosmetics when formulated to be non-irritating. The Panel cautions that these ingredients should not be used in cosmetic products in which N-nitroso compounds can be formed.
| Field | CIR value |
|---|---|
| Primary ingredient | Fatty Acyl Sarcosines and Sarcosinate Salts |
| CIR verdict | safe with restrictions |
| Report type | Safety Assessment |
| Date | 3 In 1987 |
| CAS numbers | 97-78-9, 110-25-8, 142-48-3, 137-16-6, 4028-10-8 |
| Conditions or carve-outs | When formulated to be non-irritating; Not reported to be in current use |
Ingredients Reviewed
The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Fatty Acyl Sarcosines and Sarcosinate Salts.
Safety Conclusion
The conclusion for Fatty Acyl Sarcosines and Sarcosinate Salts should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.
Conditions
When formulated to be non-irritating; Not reported to be in current use
Formulation Reading
For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Fatty Acyl Sarcosines and Sarcosinate Salts, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.
The ingredient hub at Fatty Acyl Sarcosines and Sarcosinate Salts should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.
Why This Page Exists
CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Fatty Acyl Sarcosines and Sarcosinate Salts, with source details retained at the bottom for audit.
Review Notes
The conservative reading is to keep Fatty Acyl Sarcosines and Sarcosinate Salts tied to the exact CIR report listed below. The ingredient family, panel conclusion, date, and any use-condition language belong together. A shorter ingredient-page snippet would lose that context.
This page gives the search-level answer while preserving the source-level caveat: CIR safety language is a panel assessment for cosmetic practices of use, not a universal legal permission across every jurisdiction or product category.
Source
- CIR report: Amended Safety Assessment of Fatty Acyl Sarcosines and Sarcosinate Salts as Used in Cosmetics Monice M. Fiume*, Wilma F. Bergfeld**, Donald V. Belsito**, Ronald A. Hill***, Curtis D. Klaassen**, Daniel C. Liebler**, James G. Marks Jr.***, R
- CIR source file: PRS719.pdf
- Extraction JSON: CIR Safety Assessment Database
- Conclusion page in CIR extraction: 15